5-(7-Methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo [2,3-d] In the title compound, C 15 H 20 N 7 O 3 S + ÁCH 3 O 3 S À (CH5132799 mesylate), two molecular entities form a salt with proton transfer from methanesulfonic acid to the aminopyrimidine moiety of CH5132799. In the crystal, methanesulfonate is retained by bifurcated OÁ Á ÁH-N hydrogen bonds and an N + -HÁ Á ÁO À chargeassisted hydrogen bond.
Structure description
5-(7-Methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo [2,3-d] pyrimidin-4-yl)-pyrimidin-2-ylamine (CH5132799) was synthesized as an antitumor PI3K inhibitor (Ohwada et al., 2011; Tanaka et al., 2011) and crystallized with methanesulfonic acid to improve its aqueous solubility. Single crystal X-ray structure analysis revealed that the three S-O bond lengths of methanesulfonate to be 1.444 (2), 1.473 (2), and 1.475 (2) Å , and it was confirmed that CH5132799 and methanesulfonic acid form a molecular salt with proton transfer from methanesulfonic acid to the aminopyrimidine moiety of CH5132799. In the crystal, methanesulfonate is retained by bifurcated O30Á Á ÁH19B(H19A#)-N19(N19#) hydrogen bonds and an N + 17-H17Á Á ÁO À 28 chargeassisted hydrogen bond (Figs. 1 and 2, and Table 1 ).
Synthesis and crystallization
CH5132799 was synthesized according to the patented process (Shimma et al., 2008; Ebiike et al., 2009 ). CH5132799 (1.0 eq.) was added to a stirred solution of methane-
data reports sulfonic acid (2.3 weq.) and water (2.5 weq.). l-Cysteine (0.058 weq.) was then added to the solution and the mixture was continuously stirred for an additional 3 h. The resulting solution was filtered, and the equipment was rinsed with a solution of methanesulfonic acid (0.22 weq.) and water (2.1 weq.). The filtrate and the rinse were combined, and acetone (6.2 veq.) was added slowly to this stirred solution at room temperature. Stirring was continued for at least 2 h and the presence of the solids was confirmed. Further acetone (19 veq.) was added to the mixture, which was stirred for an additional hour at the same temperature. This mixture was then filtered, and the solids were washed twice with acetone (each 4.0 veq). The solids were collected and dried under reduced pressure to afford CH5132799 mesylate as yellow crystals (typical yield 90%).
Refinement
Crystal data, data collection, and refinement details are summarized in Table 2 Hydrogen-bond geometry (Å , ). Symmetry codes: (i) Àx þ 2; Ày þ 1; Àz þ 1; (ii) x; y À 1; z þ 1. 
Figure 1
The molecular structure of the title compound. Displacement ellipsoids for non-H atoms are drawn at the 50% probability level.
Figure 2
Hydrogen bonds in the crystal structure of the title compound (dashed lines). The suffix # in atom labels indicates atoms related by an inversion center. Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. Refinement. Refinement was performed using all reflections. The weighted R-factor (wR) and goodness of fit (S) are based on F 2 . R-factor (gt) are based on F. The threshold expression of F 2 > 2.0 sigma (F 2 ) is used only for calculating Rfactor (gt). 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (

